You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
McKinsey
AstraZeneca
Mallinckrodt
Medtronic

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Patent: 5,959,094

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,959,094
Title: p75 TNF receptor promoters
Abstract:The present invention is an isolated DNA molecule comprising a promoter of the human p75 TNF-R gene having a sequence consisting of a 5\' upstream promoter sequence contained within an approximately 2.0 kbp NcoI fragment of a genomic clone of human p75 TNF-R, or an intron promoter sequence located in the first intron between the first and second exons and contained within an approximately 1.9 kbp SmaI fragment of a genomic clone of human p75 TNF-R. A composition comprising the DNA molecule and a carrier is also described.
Inventor(s): Wallach; David (Rehovot, IL), Kuhnert; Peter (Berne, CH), Ehrhardt; Gotz (Steisslingen, DE), Kemper; Oliver (Bockenheim, DE)
Assignee: Yeda Research and Development Co. Ltd. (Rehovot, IL)
Application Number:08/737,371
Patent Claims:see list of patent claims

Details for Patent 5,959,094

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Yeda Research and Development Co. Ltd. (Rehovot, IL) 2014-05-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Yeda Research and Development Co. Ltd. (Rehovot, IL) 2014-05-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Yeda Research and Development Co. Ltd. (Rehovot, IL) 2014-05-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Mallinckrodt
Express Scripts
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.